Terms: = Lung cancer AND KMT2A, TRX1, 4297, MLL, ENSG00000118058, MLL/GAS7, HTRX1, HRX, ALL-1, MLL1A, CXXC7 AND Diagnosis
17 results:
1. [Primary lung salivary gland-type duct carcinoma: a clinicopathological analysis of two cases and review of literature].
Li SL; Wu CY; Hou LK; Xie HK; Wu W; Zhang W; Zhang LP
Zhonghua Bing Li Xue Za Zhi; 2022 Mar; 51(3):218-223. PubMed ID: 35249285
[No Abstract] [Full Text] [Related]
2. The blood level of thioredoxin 1 as a supporting biomarker in the detection of breast cancer.
Lee YJ; Kim Y; Choi BB; Kim JR; Ko HM; Suh KH; Lee JS
BMC Cancer; 2022 Jan; 22(1):12. PubMed ID: 34979986
[TBL] [Abstract] [Full Text] [Related]
3. Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and kmt2a-rearranged AML.
Menghrajani K; Gomez-Arteaga A; Madero-Marroquin R; Zhang MJ; Bo-Subait K; Sanchez J; Wang HL; Aljurf M; Assal A; Bacher VU; Badawy SM; Bejanyan N; Bhatt VR; Bredeson C; Byrne M; Castillo P; Cerny J; Chhabra S; Ciurea SO; DeFilipp Z; Farhadfar N; Gadalla S; Gale RP; Ganguly S; Gowda L; Grunwald MR; Hashmi S; Hildebrandt G; Kanakry CG; Kansagra A; Khimani F; Krem M; Lazarus H; Liu H; Martino R; Michelis FV; Nathan S; Nishihori T; Olsson R; Reshef R; Rizzieri D; Rowe JM; Savani BN; Seo S; Sharma A; Solh M; Ustun C; Verdonck LF; Hourigan C; Sandmaier B; Litzow M; Kebriaei P; Weisdorf D; Zhang Y; Tallman MS; Saber W
Blood Adv; 2022 Jan; 6(3):828-847. PubMed ID: 34551064
[TBL] [Abstract] [Full Text] [Related]
4. Thymic adenocarcinoma accompanied by type A thymoma and pulmonary minimally invasive adenocarcinoma and harboring distinct gene alterations: A case report.
Zheng YW; Bai LL; Jiang GY; Lin XY; Liu Y; Xu HT
Medicine (Baltimore); 2021 Apr; 100(15):e25254. PubMed ID: 33847622
[TBL] [Abstract] [Full Text] [Related]
5. H3K4 Methylation Status and Lysine Specific Methyltransferase KMT2C Expression Correlate with Prognosis in lung Adenocarcinoma.
Bosgana P; Nikou S; Dimitrakopoulos FI; Logotheti S; Tzelepi V; Kalophonos C; Bravou V; Kourea E; Sampsonas F; Zolota V
Curr Mol Pharmacol; 2021; 14(6):1028-1036. PubMed ID: 32867667
[TBL] [Abstract] [Full Text] [Related]
6. Disclosing progress in cancer survival with less delay.
Jansen L; Schröder CC; Emrich K; Holleczek B; Pritzkuleit R; Brenner H
Int J Cancer; 2020 Aug; 147(3):838-846. PubMed ID: 31785152
[TBL] [Abstract] [Full Text] [Related]
7. Integrative Genomic Characterization Identifies Molecular Subtypes of lung Carcinoids.
Laddha SV; da Silva EM; Robzyk K; Untch BR; Ke H; Rekhtman N; Poirier JT; Travis WD; Tang LH; Chan CS
Cancer Res; 2019 Sep; 79(17):4339-4347. PubMed ID: 31300474
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of the
McDermott S; Kilcoyne A; Wang Y; Scott JA; Halpern EF; Ackman JB
Clin Radiol; 2019 Mar; 74(3):187-195. PubMed ID: 30638605
[TBL] [Abstract] [Full Text] [Related]
9. [Metastases to the breast from non-mammary malignancies: a clinicopathologic study of 28 cases].
Zhou S; Yu B; Cheng Y; Xu X; Shui R; Bi R; Lu H; Tu X; Yang W
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):231-5. PubMed ID: 24915812
[TBL] [Abstract] [Full Text] [Related]
10. Is soluble mesothelin-related protein an upfront predictive marker of pleural mesothelioma? A prospective study on Italian workers exposed to asbestos.
Filiberti R; Marroni P; Spigno F; Merlo DF; Mortara V; Caruso P; Cioè A; Michelazzi L; Bruzzone A; Bobbio B; Simonassi C; Del Corso L; Galli R; Racchi O; Dini G; Linares R; Mencoboni M
Oncology; 2014; 86(1):33-43. PubMed ID: 24401539
[TBL] [Abstract] [Full Text] [Related]
11. Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses.
Park BJ; Cha MK; Kim IH
BMC Res Notes; 2014 Jan; 7():7. PubMed ID: 24393391
[TBL] [Abstract] [Full Text] [Related]
12. [Considerations about the epidemiologic surveillance system on mesothelioma in Tuscany (Italy) after 25 years of activity].
Chellini E; Martini A; Cacciarini V; Badiali AM;
Epidemiol Prev; 2013; 37(1):43-50. PubMed ID: 23585433
[TBL] [Abstract] [Full Text] [Related]
13. [Acute lymphoblastic leukemia with t(4;11)(q21;q23) after iodine-131 treatment for thyroid cancer].
Iuchi Y; Sato K; Jimbo J; Inamura J; Shindo M; Ikuta K; Shinzaki H; Ohnishi K; Watanabe S; Torimoto Y; Kohgo Y
Rinsho Ketsueki; 2005 Nov; 46(11):1202-7. PubMed ID: 16440804
[TBL] [Abstract] [Full Text] [Related]
14. High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities.
Ishizawa S; Slovak ML; Popplewell L; Bedell V; Wrede JE; Carter NH; Snyder DS; Arber DA
Leukemia; 2003 Jun; 17(6):1091-5. PubMed ID: 12764373
[TBL] [Abstract] [Full Text] [Related]
15. Chronic eosinophilic leukemia with t(6;11)(q27;q23) translocation.
Suzuki S; Chiba K; Toyoshima N; Kurosawa M; Hashino S; Musashi M; Asaka M
Ann Hematol; 2001 Sep; 80(9):553-6. PubMed ID: 11669308
[TBL] [Abstract] [Full Text] [Related]
16. Detection of major and minor bcr/abl fusion gene transcripts in a patient with acute undifferentiated leukemia secondary to treatment with an alkylating agent.
Hattori M; Tanaka M; Yamazaki Y; Nakahara Y; Tsushita K; Utumi M
Leuk Res; 1995 Jun; 19(6):389-96. PubMed ID: 7596151
[TBL] [Abstract] [Full Text] [Related]
17. [Recent status of the diagnosis and treatment of bone metastasis in patients with advanced lung cancer].
Eguchi K; Saijo N; Shinkai T; Sasaki Y; Tamura T; Sakurai M; Oyamada H; Terui K; Fukuma H; Beppu Y
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1696-703. PubMed ID: 3036014
[TBL] [Abstract] [Full Text] [Related]
